Stéphanie Forté: New Insights on Stroke in Adults with Sickle Cell Disease
Stéphanie Forté, Medical Lead of the Red Blood Cell Disorders Comprehensive Centre (SANGRE) at CHUM, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in The British Journal of Haematology, adding:
“Stroke and Sickle Cell Disease: A Montreal Study Highlights Lasting Impacts in Adults
The British Journal of Haematology publishes a study led by our team at University of Montreal Health Centre (CHUM), the CHUM Research Centre, and the University of Montreal, shedding light on an underrecognized reality: stroke in adults living with sickle cell disease (SCD).
Sickle cell disease is a genetic blood disorder that primarily affects individuals of African and Caribbean descent.
While stroke risk is well established in children, much less is known about its impact in adults.
In a cohort of 454 adults followed at CHUM, we found that nearly 1 in 20 had experienced a stroke.
Importantly, these events were not limited to the most severe genotypes, but also occurred in forms often perceived as ‘milder.’
The consequences are often long-lasting:
- cognitive impairment (memory and attention)
- reduced functional independence
This work reflects a strong multidisciplinary collaboration between researchers in hematology, vascular neurology (ICranium), and highly engaged trainees.
Special recognition to Jonathan St-Onge, future hematology resident at Université de Montréal, for his teamwork, perseverance, and dedication to advancing care and research.
‘Sickle cell disease is a lifelong condition, and its neurological complications in adulthood remain underrecognized and require greater attention.’
Our findings highlight the need for:
- improved stroke prevention strategies in SCD
- early recognition of neurological symptoms
- specialized, structured care for adults
This work also contributes to a broader effort to address health inequities — a key focus of Black History Month.”
Title: Stroke burden and functional impacts in adults with sickle cell disease
Authors: Jonathan St-Onge, Tzvetena Hristova, Chrystelle Charles, Olena Bereznyakova, Gregory Jacquin, Olivier Pouliot, Janick Caron-Lecuyer, Mia Stevanovik, Sara-Maude Desforges, Costa M. Kazadi, Julian Alejandro Rivillas, Christian Stapf, Stéphanie Forté
Read the Full Article on The British Journal of Haematology

Find the latest updates on Hemostasis Today.
-
Oct 4, 2026, 15:06Vasiliki Gkalea: Journal of Clinical Medicine Launches Special Issue on Hematologic Thrombosis and Bleeding
-
Oct 4, 2026, 14:55Quentin Brebant: What Defines a High-Quality Red Blood Cell Concentrate?
-
Oct 4, 2026, 14:47Rana Al-Hrout: Recognizing Non-Anemic Iron Deficiency – Why Iron Matters Beyond Hemoglobin
-
Oct 4, 2026, 14:41David McIntosh: International Plasma Awareness Week 2026 – Closing the Global Plasma Gap
-
Oct 4, 2026, 14:33Pete Stibbs: CleanerVac Real-World Study Presented at VIVA and The VEINS 2026
-
Oct 4, 2026, 13:56Maria Elisa Mancuso: EHC 2026 Highlights the Unmet Needs of Women with Bleeding Disorders
-
Oct 4, 2026, 13:53Nirmal Shaji George: Individualizing Anticoagulation in Complex APS and Thrombocytopenia
-
Oct 4, 2026, 13:5210 Posts Not to Miss This Week
-
Oct 4, 2026, 13:45Suswapna Singh Rawat: The Clinical Significance of Coronary Plaque Stability